TCTR20171206003已完成未知
Correction of Vitamin D Deficiency in Chronic Hepatitis C Patients who Had Sustained Virologic Response After Direct-acting Agent Therapy : Effect on Serum Hepatic Fibrogenesis Markers
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •Age 18 years
- •Chronic hepatitis C with sustained virologic response after direct-acting agent
- •Evidence of liver fibrosis from fibroscan, MRE or ultrasound
排除标准
- •Decompensated liver cirrhosis
- •Chronic liver disease or cirrhosis from other causes
- •HIV infection, autoimmune disease, malignancy, asthma or COPD
- •Pregnancy and/or lactation woman
- •Active viral or bacterial infection
- •History of steroids or immunosuppressive therapy in 6 months before enrollment
- •History of interferons-based therapy within 1 year
- •History of active alcohol drinking in 6 months before enrollment
- •Chronic kidney disease (GFR ≤ 60 ml/min)
研究者
相似试验
已完成
4 期
Correction of vitamin D deficiency in chronic hepatitis C patients and effect on cytokines responses related to liver fibrotic pathway: A Randomized Double-Blind Placebo Control StudyChronic hepatitis C patientliver fibrosis,chronic hepatitis C,vitamin D suppelmentTCTR20161103003The Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University58
进行中（未招募）
不适用
Correction of vitamin D deficiency in critically ill patients: a randomized, doulbe-blind, placebo-controlled trialCritically ill patients with vitamin D deficiencyEUCTR2010-018798-39-ATMedizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Endokrinologie480
进行中（未招募）
不适用
Evaluation of the effects of chronic treatment with vitamin D in patients with chronic heart failure and low level of vitamin DEUCTR2011-001726-14-ITAUSL DI MODENA80
招募中
3 期
A clinical trial to study the effect of Vitamin D in patients of systemic lupus erythematosus.CTRI/2017/07/009033Bidyut Kumar Das
已完成
1 期
Vitamin D supplementation for the treatment of non alcoholic fatty liver disease: a randomized double blind placebo controlled trialON ALCOHOLIC FATTY LIVER DISEASE.IRCT201612077732N2Vice Chancellor for Research, Shiraz University of Medical Sciences106